Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Mouse Model
77%
Cytokine
75%
Inflammation
63%
Asthma
58%
Anti-Inflammatory Drug
49%
Pneumonia
47%
Antiinflammatory Activity
44%
Lung Cancer
43%
Escherichia Coli O157
41%
Allergic Asthma
40%
Tumor Necrosis Factor
38%
Placebo
37%
Antimicrobial Agent
36%
Interleukin 6
35%
Lipopolysaccharide
34%
Nuclear Factor
33%
Alternative Complement Pathway C3 C5 Convertase
33%
Transcription Factor Nrf2
33%
Malignant Neoplasm
32%
Randomized Controlled Trial
29%
Acute Lung Injury
26%
Transcriptome
24%
Rose
24%
Lipopolysaccharide-Induced Lung Inflammation
24%
Bleomycin-Induced Pulmonary Fibrosis
24%
Ethanol
22%
Respiratory Tract Disease
22%
Respiratory Tract Allergy
21%
Inducible Nitric Oxide Synthase
21%
Inflammatory Disease
20%
Therapeutic Effect
19%
Fibrosing Alveolitis
19%
Interleukin 1
18%
Lung Fibrosis
17%
Protein Kinase B
17%
Rat
17%
Adverse Event
16%
Radiation Pneumonia
16%
Alisma
16%
Nephrotoxicity
16%
Sophora flavescens
16%
Cisplatin
16%
Hypolipemia
16%
Agrimonia Pilosa Extract
16%
Cholinesterase Inhibitor
16%
Chronic Cough
16%
Lonicera japonica
16%
Antioxidant
16%
Acetylcholinesterase
16%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
60%
Homeopathy
49%
Meta-Analysis
49%
Asthma
45%
Lung Cancer
41%
Manual Therapy
33%
Radiation Pneumonia
33%
Oral Drug Administration
33%
Adjuvant Therapy
27%
Randomized Controlled Trial
21%
Acupuncture
20%
Placebo
17%
Traditional Korean Medicine
17%
Network Meta-Analysis
16%
Cancer-Related Fatigue
16%
Chronic Cough
16%
Gastroesophageal Reflux
16%
Exercise
15%
Forced Expiratory Volume
13%
Korean Medicine
12%
Herbaceous Agent
11%
Adverse Event
11%
Lung Function
10%
Methylation
9%
Acupuncture Treatment
9%
COVID-19
9%
Coughing
8%
Lung
8%
In Vitro
8%
Electroacupuncture
8%
Beta-Endorphin
8%
Substance P
8%
Cancer Pain
8%
Mitogen-Activated Protein Kinase
8%
Inhalational Drug Administration
8%
Allergic Rhinitis
8%
Analgesia
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Acute Lung Injury
8%
Pancreatic Elastase
8%
Elastase
8%
Lipopolysaccharide-Induced Lung Inflammation
8%
Dipeptidyl Carboxypeptidase
8%
Enzyme Polymorphism
8%
Random Effects Model
6%
Independent Reviewer
6%
Patient with Asthma
6%
Glycosylphosphatidylinositol
6%
Cell Surface Protein
6%
Drug Therapy
6%
Immunology and Microbiology
Antiinflammatory Activity
46%
Lung
35%
Escherichia Coli O157:H7
33%
Airway
30%
Pulmonary Inflammation
26%
Gene Expression Assay
24%
Antimicrobial Agent
24%
Allergic Asthma
21%
Asthma
20%
Pneumonitis
16%
Complement Factor B
16%
Houttuynia cordata
16%
Lonicera japonica
16%
Peritoneal Macrophage
16%
Rose
16%
Agrimonia Pilosa Extract
16%
Revertant
16%
Tumor Cell
16%
Cancer Immunotherapy
16%
Cytokine
15%
Tumor Necrosis Factor
14%
Immunoglobulin E
13%
Interleukin 6
13%
Particulate Matter
12%
Secretion (Process)
11%
Epithelium
11%
Interleukin 4
11%
Neutrophil
11%
Interleukin 1
11%
Inflammation Response
9%
Bronchoalveolar Lavage Fluid
8%
Transcription Factor Nrf2
8%
Scutellaria barbata
8%
Sinapis
8%
Paeonia suffruticosa
8%
Curcuma
8%
Peak Expiratory Flow
8%
Forced Expiratory Volume
8%
Chrysanthemum
8%
Gleditsia
8%
Hematopoiesis
8%
Hematopoietic Cell
8%
STAT5
8%
Respiratory Tract Allergy
8%
Kinase
8%
Phosphotransferase
8%
Immunoglobulin Enhancer Binding Protein
8%
Electric Potential
8%
Immunotherapy
8%
Transcription Factor NANOG
8%